- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Azitra Inc (AZTR)
The Azitra share price today is 0.2325, view NYSE AZTR stock exchange data. Track the latest Azitra share price with real-time updates on AZTR stock performance including market cap, day range, 52-week range and dividend yield. Access AZTR charts, earnings dates and analyst estimates to support your investment decisions.
0.2325
-0.0052(-2.19%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.2310
0.2399
52 wk Range
0.1000
2.3976
Earnings results expected today
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.23100.2399
52 wk Range
0.10002.3976
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AZTR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
1.3500
Upside
+480.65%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 1.3500
(+480.65% Upside)
Earnings
Latest Release
28-02-2026
EPS / Forecast
1.15 / -0.22
Revenue / Forecast
-- / --
Compare AZTR to Peers and Sector
Metrics to compare | AZTR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAZTRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.3x | −18.2x | −0.6x | |
PEG Ratio | 0.00 | −0.02 | 0.00 | |
Price/Book | 1.0x | 6.8x | 2.6x | |
Price / LTM Sales | - | 6.2x | 3.2x | |
Upside (Analyst Target) | - | 67.7% | 48.1% | |
Fair Value Upside | Unlock | 10.1% | 5.8% | Unlock |
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically modified strain of S. epidermidis, which is in a Phase 1b/2a clinical trial for treating Netherton syndrome, a skin disease; and ATR-01, a genetically modified strain of S. epidermidis that expresses an engineered recombinant human filaggrin protein, which is in the IND-enabling phase for treating ichthyosis vulgaris, a skin disease. It has a joint development agreement with Bayer for the identification and characterization of S. epidermidis strains for topical formulations. Azitra, Inc. was incorporated in 2014 and is headquartered in Branford, Connecticut.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Azitra (AZTR) Share Price Today?
The Azitra share price today is 0.2325.
What is the current Azitra (AZTR) share price and day range?
As of 08-05-2026, the Azitra share price is 0.2325, with a previous close of 0.2377. The share price has ranged from 0.2310 to 0.2399 today, while the 52-week range spans from 0.1000 to 2.3976.
What Is the Azitra Market Cap?
As of today, Azitra market cap is 3.8500M.
What Is the Azitra (AZTR) Share Price Target?
The average 12-month share price target for Azitra is 1.3500, with a high estimate of 1.7 and a low estimate of 1. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +480.65% Upside potential.
What Is Azitra's Earnings Per Share (TTM)?
The Azitra EPS (TTM) is -2.2479.
When Is the Next Azitra Earnings Date?
Azitra will release its next earnings report on 08-05-2026.
From a Technical Analysis Perspective, Is AZTR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Azitra Trade On?
Azitra is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Azitra?
The stock symbol for Azitra is "AZTR."
How Many Times Has Azitra Stock Split?
Azitra has split 2 times.
How Many Employees Does Azitra Have?
Azitra has 13 employees.
What Is the AZTR Premarket Price?
AZTR's last pre-market stock price is 0.2321. The pre-market share volume is 8,470.0000, and the stock has changed by -0.0056, or -2.3600%.
What Is the AZTR After Hours Price?
AZTR's last after hours stock price is 0.2378, the stock has changed by 0.0001, or 0.0400%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.